Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

[Giving a future to transgender youth… What do we currently know of their needs, what are the best practices ?]

Medico D, Zufferey A.

Rev Med Suisse. 2018 Oct 3;14(621):1765-1769. French.

PMID:
30303329
2.

Antiplatelet antibody-induced thrombocytopenia does not correlate with megakaryocyte abnormalities in murine immune thrombocytopenia.

Guo L, Kapur R, Aslam R, Hunt K, Hou Y, Zufferey A, Speck ER, Rondina MT, Lazarus AH, Ni H, Semple JW.

Scand J Immunol. 2018 Jul;88(1):e12678. doi: 10.1111/sji.12678.

3.

Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration.

Cloutier N, Allaeys I, Marcoux G, Machlus KR, Mailhot B, Zufferey A, Levesque T, Becker Y, Tessandier N, Melki I, Zhi H, Poirier G, Rondina MT, Italiano JE, Flamand L, McKenzie SE, Cote F, Nieswandt B, Khan WI, Flick MJ, Newman PJ, Lacroix S, Fortin PR, Boilard E.

Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1550-E1559. doi: 10.1073/pnas.1720553115. Epub 2018 Jan 31.

4.

Mature murine megakaryocytes present antigen-MHC class I molecules to T cells and transfer them to platelets.

Zufferey A, Speck ER, Machlus KR, Aslam R, Guo L, McVey MJ, Kim M, Kapur R, Boilard E, Italiano JE Jr, Semple JW.

Blood Adv. 2017 Sep 8;1(20):1773-1785. doi: 10.1182/bloodadvances.2017007021. eCollection 2017 Sep 12.

5.

Which priority indicators to use to evaluate nursing care performance? A discussion paper.

Dubois CA, D'amour D, Brault I, Dallaire C, Déry J, Duhoux A, Lavoie-Tremblay M, Mathieu L, Karemere H, Zufferey A.

J Adv Nurs. 2017 Dec;73(12):3154-3167. doi: 10.1111/jan.13373. Epub 2017 Aug 1. Review.

PMID:
28661049
6.

Pathogenesis and Therapeutic Mechanisms in  Immune Thrombocytopenia (ITP).

Zufferey A, Kapur R, Semple JW.

J Clin Med. 2017 Feb 9;6(2). pii: E16. doi: 10.3390/jcm6020016. Review.

7.

T regulatory cells and dendritic cells protect against transfusion-related acute lung injury via IL-10.

Kapur R, Kim M, Aslam R, McVey MJ, Tabuchi A, Luo A, Liu J, Li Y, Shanmugabhavananthan S, Speck ER, Zufferey A, Yousef G, Zhang H, Rondina MT, Weyrich AS, Porcelijn L, Kuebler WM, Slutsky AS, Semple JW.

Blood. 2017 May 4;129(18):2557-2569. doi: 10.1182/blood-2016-12-758185. Epub 2017 Feb 15.

8.

Platelet microvesicles in health and disease.

Melki I, Tessandier N, Zufferey A, Boilard E.

Platelets. 2017 May;28(3):214-221. doi: 10.1080/09537104.2016.1265924. Epub 2017 Jan 19. Review.

PMID:
28102737
9.

The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia.

Aslam R, Kapur R, Segel GB, Guo L, Zufferey A, Ni H, Semple JW.

Exp Hematol. 2016 Oct;44(10):924-930.e1. doi: 10.1016/j.exphem.2016.07.004. Epub 2016 Jul 12.

PMID:
27417974
10.

New molecular insights into modulation of platelet reactivity in aspirin-treated patients using a network-based approach.

Zufferey A, Ibberson M, Reny JL, Nolli S, Schvartz D, Docquier M, Xenarios I, Sanchez JC, Fontana P.

Hum Genet. 2016 Apr;135(4):403-414. doi: 10.1007/s00439-016-1642-1. Epub 2016 Feb 16.

PMID:
26883867
11.

CD20+ B-cell depletion therapy suppresses murine CD8+ T-cell-mediated immune thrombocytopenia.

Guo L, Kapur R, Aslam R, Speck ER, Zufferey A, Zhao Y, Kim M, Lazarus AH, Ni H, Semple JW.

Blood. 2016 Feb 11;127(6):735-8. doi: 10.1182/blood-2015-06-655126. Epub 2015 Nov 10.

12.

Aspirin response: Differences in serum thromboxane B2 levels between clinical studies.

Brun C, Daali Y, Combescure C, Zufferey A, Michelson AD, Fontana P, Reny JL, Frelinger AL 3rd.

Platelets. 2016;27(3):196-202. doi: 10.3109/09537104.2015.1072147. Epub 2015 Aug 13.

PMID:
26270593
13.

Nouvelle cuisine: platelets served with inflammation.

Kapur R, Zufferey A, Boilard E, Semple JW.

J Immunol. 2015 Jun 15;194(12):5579-87. doi: 10.4049/jimmunol.1500259. Review.

14.

Functional role of a polymorphism in the Pannexin1 gene in collagen-induced platelet aggregation.

Molica F, Morel S, Meens MJ, Denis JF, Bradfield PF, Penuela S, Zufferey A, Monyer H, Imhof BA, Chanson M, Laird DW, Fontana P, Kwak BR.

Thromb Haemost. 2015 Aug;114(2):325-36. doi: 10.1160/TH14-11-0981. Epub 2015 May 7.

PMID:
25947940
15.

Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins.

Finamore F, Priego-Capote F, Nolli S, Zufferey A, Fontana P, Sanchez JC.

J Proteomics. 2015 Jan 30;114:125-35. doi: 10.1016/j.jprot.2014.11.005. Epub 2014 Nov 20.

PMID:
25464367
16.

Characterization of the platelet granule proteome: evidence of the presence of MHC1 in alpha-granules.

Zufferey A, Schvartz D, Nolli S, Reny JL, Sanchez JC, Fontana P.

J Proteomics. 2014 Apr 14;101:130-40. doi: 10.1016/j.jprot.2014.02.008. Epub 2014 Feb 16.

PMID:
24549006
17.

Antiplatelet therapy: targeting the TxA2 pathway.

Fontana P, Zufferey A, Daali Y, Reny JL.

J Cardiovasc Transl Res. 2014 Feb;7(1):29-38. doi: 10.1007/s12265-013-9529-1. Epub 2013 Dec 19. Review.

PMID:
24353037
18.

EasyProt--an easy-to-use graphical platform for proteomics data analysis.

Gluck F, Hoogland C, Antinori P, Robin X, Nikitin F, Zufferey A, Pasquarello C, Fétaud V, Dayon L, Müller M, Lisacek F, Geiser L, Hochstrasser D, Sanchez JC, Scherl A.

J Proteomics. 2013 Feb 21;79:146-60. doi: 10.1016/j.jprot.2012.12.012. Epub 2012 Dec 28.

PMID:
23277275
19.

Platelet proteomics.

Zufferey A, Fontana P, Reny JL, Nolli S, Sanchez JC.

Mass Spectrom Rev. 2012 Mar-Apr;31(2):331-51. doi: 10.1002/mas.20345. Epub 2011 Oct 18. Review.

PMID:
22009795
20.

Platelet reactivity is a stable and global phenomenon in aspirin-treated cardiovascular patients.

Zufferey A, Reny JL, Combescure C, de Moerloose P, Sanchez JC, Fontana P.

Thromb Haemost. 2011 Sep;106(3):466-74. doi: 10.1160/TH11-04-0226. Epub 2011 Jul 4.

PMID:
21725581
21.

[Antiplatelet agents: which one, when and for whom?].

Reny JL, Zufferey A, Berdagué P, Fontana P.

Rev Med Interne. 2010 Dec;31 Suppl 3:S339-41. doi: 10.1016/j.revmed.2010.09.019. Epub 2010 Oct 29. French. No abstract available.

PMID:
21035923
22.

Synthesis and characterization of dimeric venom peptides.

Vizzavona J, Zufferey A, Rose K.

Adv Exp Med Biol. 2009;611:493-4. No abstract available.

PMID:
19400280
23.

Cumulative risk factors for adolescent alcohol misuse and its perceived consequences among 16 to 20 year old adolescents in Switzerland.

Zufferey A, Michaud PA, Jeannin A, Berchtold A, Chossis I, van Melle G, Carles Suris J.

Prev Med. 2007 Aug-Sep;45(2-3):233-9. Epub 2007 May 13.

PMID:
17573102

Supplemental Content

Loading ...
Support Center